Synthetic Cathinones: A New Public Health Problem
暂无分享,去创建一个
Laurent Karila | Bruno Megarbane | Michel Lejoyeux | B. Mégarbane | O. Cottencin | L. Karila | M. Lejoyeux | Olivier Cottencin
[1] M. Forster,et al. Locomotor stimulant and discriminative stimulus effects of ‘bath salt’ cathinones , 2013, Behavioural pharmacology.
[2] M. Liechti,et al. Pharmacological characterization of designer cathinones in vitro , 2013, British journal of pharmacology.
[3] N. Sadeg,et al. Methcathinone: a new postindustrial drug. , 2005, Forensic science international.
[4] P. Dargan,et al. The European Drug Emergencies Network (Euro-DEN) , 2014, Clinical toxicology.
[5] J. Cisek,et al. Methcathinone: a Russian designer amphetamine infiltrates the rural midwest. , 1993, Annals of emergency medicine.
[6] T. Penders,et al. Intoxication Delirium following Use of Synthetic Cathinone Derivatives , 2012, The American journal of drug and alcohol abuse.
[7] F. Schifano,et al. Suspected and Confirmed Fatalities Associated With Mephedrone (4-Methylmethcathinone, “Meow Meow”) in the United Kingdom , 2012, Journal of clinical psychopharmacology.
[8] J. Camarasa,et al. Comparative neuropharmacology of three psychostimulant cathinone derivatives: butylone, mephedrone and methylone , 2012, British journal of pharmacology.
[9] G. Reisfield,et al. Psychoactive "bath salts" intoxication with methylenedioxypyrovalerone. , 2012, The American journal of medicine.
[10] M. St-Onge,et al. Seizures and Hyponatremia Related to Ethcathinone and Methylone Poisoning , 2011, Journal of Medical Toxicology.
[11] T. Dickerson,et al. The novel recreational drug 3,4-methylenedioxypyrovalerone (MDPV) is a potent psychomotor stimulant: Self-administration and locomotor activity in rats , 2013, Neuropharmacology.
[12] Kurt R. Lehner,et al. Powerful Cocaine-Like Actions of 3,4-Methylenedioxypyrovalerone (MDPV), a Principal Constituent of Psychoactive ‘Bath Salts’ Products , 2013, Neuropsychopharmacology.
[13] Schedules of controlled substances: temporary placement of three synthetic cathinones in Schedule I. Final Order. , 2011, Federal register.
[14] C. R. Clark,et al. Synthetic cathinones: "a khat and mouse game". , 2014, Toxicology letters.
[15] J. Zawilska,et al. Designer cathinones--an emerging class of novel recreational drugs. , 2013, Forensic science international.
[16] M. Coppola,et al. 3,4-methylenedioxypyrovalerone (MDPV): chemistry, pharmacology and toxicology of a new designer drug of abuse marketed online. , 2012, Toxicology letters.
[17] American Association of Poison Control Centers , 1966 .
[18] Derrick J Pounder,et al. Mephedrone (4-methylmethcathinone)-related deaths. , 2011, Journal of analytical toxicology.
[19] A. D. Krikorian,et al. Kat and its use: an historical perspective. , 1984, Journal of ethnopharmacology.
[20] Mark Mitchelson,et al. Mephedrone toxicity in a Scottish emergency department , 2010, Emergency Medicine Journal.
[21] P. Dargan,et al. Using poisons information service data to assess the acute harms associated with novel psychoactive substances. , 2014, Drug testing and analysis.
[22] Laurent Karila,et al. New designer drugs (synthetic cannabinoids and synthetic cathinones): review of literature. , 2014, Current pharmaceutical design.
[23] P. Dargan,et al. Mephedrone use and associated adverse effects in school and college/university students before the UK legislation change. , 2010, QJM : monthly journal of the Association of Physicians.
[24] J. Ramsey,et al. Energy-1 (‘NRG-1’): don't believe what the newspapers say about it being legal , 2011, Emergency Medicine Journal.
[25] M. Zloh,et al. An analysis of the 'legal high' mephedrone. , 2010, Bioorganic & medicinal chemistry letters.
[26] Cinzia Pezzolesi,et al. Identifying emerging trends in recreational drug use; outcomes from the Psychonaut Web Mapping Project , 2012, Progress in Neuro-Psychopharmacology and Biological Psychiatry.
[27] P. Griffiths,et al. Khat use and monitoring drug use in Europe: the current situation and issues for the future. , 2010, Journal of ethnopharmacology.
[28] Henry A Spiller,et al. Clinical experience with and analytical confirmation of “bath salts” and “legal highs” (synthetic cathinones) in the United States , 2011, Clinical toxicology.
[29] P. Dalal,et al. Bath salt intoxication causing acute kidney injury requiring hemodialysis , 2012, Hemodialysis international. International Symposium on Home Hemodialysis.
[30] M. Olive,et al. Potent rewarding and reinforcing effects of the synthetic cathinone 3,4‐methylenedioxypyrovalerone (MDPV) , 2014, Addiction biology.
[31] Lewis S. Nelson,et al. The Toxicology of Bath Salts: A Review of Synthetic Cathinones , 2011, Journal of Medical Toxicology.
[32] R. Spears,et al. Clinical characteristics of mephedrone toxicity reported to the UK National Poisons Information Service , 2010, Emergency Medicine Journal.
[33] Belinda Weimer,et al. National Forensic Laboratory Information System: Midyear report 2012 , 2013 .
[34] M. Meyer,et al. Metabolism of designer drugs of abuse: an updated review. , 2010, Current drug metabolism.
[35] Ana Margarida Araújo,et al. Raising awareness of new psychoactive substances: chemical analysis and in vitro toxicity screening of ‘legal high’ packages containing synthetic cathinones , 2014, Archives of Toxicology.
[36] Frank T Peters,et al. Beta-keto amphetamines: studies on the metabolism of the designer drug mephedrone and toxicological detection of mephedrone, butylone, and methylone in urine using gas chromatography–mass spectrometry , 2010, Analytical and bioanalytical chemistry.
[37] L. Karila,et al. GHB and synthetic cathinones: clinical effects and potential consequences. , 2011, Drug testing and analysis.
[38] C. Escher,et al. [Mephedrone--Internet drug which seems to have come and stay. Fatal cases in Sweden have drawn attention to previously unknown substance]. , 2009, Lakartidningen.
[39] R. Glennon,et al. Mephedrone and methylenedioxypyrovalerone (MDPV), major constituents of “bath salts,” produce opposite effects at the human dopamine transporter , 2013, Psychopharmacology.
[40] C. Rosenbaum,et al. Here Today, Gone Tomorrow…and Back Again? A Review of Herbal Marijuana Alternatives (K2, Spice), Synthetic Cathinones (Bath Salts), Kratom, Salvia divinorum, Methoxetamine, and Piperazines , 2012, Journal of Medical Toxicology.
[41] L. King,et al. A brief history of 'new psychoactive substances'. , 2011, Drug testing and analysis.
[42] G. Hanson,et al. Bath salts and synthetic cathinones: an emerging designer drug phenomenon. , 2014, Life sciences.
[43] F. Hickson,et al. The Chemsex study: drug use in sexual settings among gay and bisexual men in Lambeth, Southwark and Lewisham , 2014 .
[44] R. Glennon,et al. Cathinone: An Investigation of Several N-Alkyl and Methylenedioxy-Substituted Analogs , 1997, Pharmacology Biochemistry and Behavior.
[45] B. Levine,et al. Multiple-drug toxicity caused by the coadministration of 4-methylmethcathinone (mephedrone) and heroin. , 2010, Journal of analytical toxicology.
[46] A. Blank. The American Association of Poison Control Centers. , 1960, Clinical toxicology.
[47] R. Gerona,et al. Psychosis from a Bath Salt Product Containing Flephedrone and MDPV with Serum, Urine, and Product Quantification , 2012, Journal of Medical Toxicology.
[48] I. McGregor,et al. Mephedrone (4‐methylmethcathinone, ‘meow’): acute behavioural effects and distribution of Fos expression in adolescent rats , 2012, Addiction biology.
[49] Kurt R. Lehner,et al. Psychoactive "bath salts": not so soothing. , 2013, European journal of pharmacology.
[50] K. Hashimoto,et al. Combined intoxication with methylone and 5-MeO-MIPT , 2007, Progress in Neuro-Psychopharmacology and Biological Psychiatry.
[51] P. Dargan,et al. Mephedrone (4-methylmethcathinone): What is new in our understanding of its use and toxicity , 2012, Progress in Neuro-Psychopharmacology and Biological Psychiatry.
[52] Iain M McIntyre,et al. Acute methylone intoxication in an accidental drowning--a case report. , 2013, Forensic science international.
[53] P. Dargan,et al. Limited use of novel psychoactive substances in South London nightclubs. , 2012, QJM : monthly journal of the Association of Physicians.
[54] Matt Anderson,et al. European Monitoring Centre for Drugs and Drug Addiction , 2014 .
[55] Cassie L. Boggs,et al. Methylenedioxypyrovalerone (“Bath Salts”),Related Death: Case Report and Review of the Literature , , 2013, Journal of forensic sciences.
[56] Maria João Valente,et al. Khat and synthetic cathinones: a review , 2013, Archives of Toxicology.
[57] K. Houseknecht,et al. Contrasting effects of d-methamphetamine, 3,4-methylenedioxymethamphetamine, 3,4-methylenedioxypyrovalerone, and 4-methylmethcathinone on wheel activity in rats. , 2012, Drug and alcohol dependence.
[58] M. Bossong,et al. Methylone and mCPP, two new drugs of abuse? , 2005, Addiction biology.